SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors

Journal of Nuclear Medicine

Volumn 37, Issue 9, 1996, Pages 1452-1456

  Schillaci, Orazio ^a,b   Scopinaro, Francesco ^a   Angeletti, Stefane ^a   Tavolaro, Rosanna ^a   Danieli, Roberta ^a   Annibale, Bruno ^a   Gualdi, Gianfranco ^a   Delle Fave, Gianfranco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE   (Italy)

Author keywords

abdominal carcinoid tumors; indium 111 pentetreotide; somatostatin receptor scintigraphy; SPECT

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ABDOMINAL SCINTISCANNING; ABDOMINAL TUMOR; ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOID; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ABDOMINAL NEOPLASMS; CARCINOID TUMOR; FEMALE; HUMANS; HYDROXYINDOLEACETIC ACID; INDIUM RADIOISOTOPES; LIVER NEOPLASMS; MALE; MIDDLE AGED; RECEPTORS, SOMATOSTATIN; SENSITIVITY AND SPECIFICITY; SOMATOSTATIN; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029761493     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Reubi JC, Kvols LK, Waser B, et al. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990;50:5969-5977.
2. Lamberts SWJ, Chayvialle JA, Krenning KP. The visualization of gastroenteropancreatic endocrine tumors. Digestion 1993;54(suppl. I):92-97.
3. Moertel CG. An odyssey in the land of small tumors. J Clin Oncol 1987;5:1503-1522.
4. Vinik AI, McLeod MK, Fig LM, et al. Clinical features, diagnosis and localization of carcinoid tumors and their management. Gastroenterol Clin North Am 1989;18:865-896.
5. Kvols LK, Moertel CG, O'Connel MJ, Schutt AJ, Rubin J, Hahn RG. Treatment of the malignant carcinoid syndrome: evaluation of a long-acting somatostatin analogue. N Engl J Med 1986;315:663-666.
6. Kvols LK, Reubi JC. Metastatic carcinoid tumors and the malignant carcinoid syndrome. Acta Oncol 1993;32:197-201.
7. Feldman JM, Blinder RA, Lucas KJ, Coleman RE. Iodine-131 metaiodobenzylguanidine scintigraphy of carcinoid tumors. J Nucl Med 1986;27:1691-1696.
8. Hanson MW, Feldman JM, Blinder RA, Moore JO, Coleman RE. Carcinoids tumors: iodine-131 MIBG scintigraphy. Radiology 1989;172:699-703.
9. Lamberts SWJ, Bakker WH, Reubi JC, et al. Somatostatin receptors imaging in the localization of endocrine tumors. N Engl J Med 1990;323:1246-1249.
10. 123I-octreotide) in the detection and localization of carcinoid and islet cells tumors. Radiology 1993;49:1583-1591.
11. 1-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci 1991;49:1583-1591.
12. 1]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci 1991;49:1593-1601.
13. Kwekkeboom DS, Krenning EP, Bakker WH, Oei HJ, Kooij PPM, Lamberts SWJ. Somatostatin analogue scintigraphy in carcinoid tumors. Eur J Nucl Med 1993;20: 283-292.
14. Carnaille B, Nocadudie M, Pattou F, et al. Scintiscans and carcinoid tumors. Surgery 1994;116:1118-1122.
15. Simpson S, Vinik AI, Harangos PJ, Lloyd RV. Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum level of neuron-specific enolase. Cancer 1984;54:1364-1369.
16. Nash SU, Said JW. Gastroenteropancreatic neuroendocrine tumors: a histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chomogranin) markers in foregut, midgut, and hindgut tumors. Am J Clin Pathol 1986;86:415-422.
17. Zimmer T, Ziegler K, Bader M, et al. Localization of neuroendocrine tumors of the upper gastrointestinal tract. Gut 1994;35:471-475.
18. Picus D, Glazer HS, Levitt RG, Husband JE. Computed tomography of abdominal carcinoid tumors. AJR 1984;143:581-584.
19. McCarthy SM, Stark DD, Moss AA, Goldberg HI. Computed tomography of malignant carcinoid disease. J Comput Assist Tomogr 1984;8:846-850.
20. Kressel HY. Strategies for magnetic resonance imaging of focal liver disease. Radiol Clin North Am 1988;26:607-617.
21. Li K, Glazer GM, Quint LE, et al. Distinction of hepatic cavernous hemangioma from hepatic metastases with MR imaging. Radiology, 1988;169:409-415.
22. 123I-metaiodobenzylguanidine. J Nucl Med 1987;28:1907-1910.
23. 131I-MIBG in the diagnosis and therapy of carcinoids. Eur J Nucl Med 1987;13:187-191.
24. Hoefnagel CA. Metaiodobenzyl-guanidine and somatostatin in oncology: role in the management of neural crest tumors. Eur J Nucl Med 1994;21:561-581.
25. Lamberts SWJ, Krenning EP, Reubi JC. The role of somatostatin and its analogs in the diagnosis and treatment of tumors. Endocrinol Rev 1991;21:450-482.
26. Bonanji J, Ur E, Mather S, et al. A scintigraphic comparison of iodine-123-metaiodobenzylguanidine and an iodine-labeled somatostatin analogue (tyr-3-octreotide) in metastatic carcinoids tumors. J Nucl Med 1992;33:1121-1124.
27. Krenning EP, Bakker WH, Kooij PPM, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-phe1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-tyr-3-octreotide. J Nucl Med 1992;33:652-658.
28. 111In-octreoscan and SPECT [abstract]. J Nucl Biol Med 1994;38:341-342.
29. 111indium-pentetreotide scintigraphy. Semin Oncol 1994; 21(suppl 13):15-20.
30. Jamar F, Fiasse R, Leners N, Pauwels S. Somatostatin receptor imaging with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors: safety, efficacy and impact on patient management. J Nucl Med 1995;36:542-549.
31. 3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993;20:716-731.
32. Pellizzari CA, Chen GTY, Speibring DR, Weichselbaum RR, Chen CT. Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr 1989;13:20-26.
33. Kessler ML, Pitluck S, Petti P, Castro JR. Integration of multimodality imaging data for radiotherapy treatment planning. Int J Radiat Oncol Biol Phys 1991;21:1653-1667.
34. Scott AM, Macapinlac HA, Divgi CR, et al. Clinical validation of SPECT and CT/MRI image registration in radiolabeled monoclonal antibody studies of colorectal carcinoma. J Nucl Med 1994;35:1976-1984.
35. Scott AM, Macapinlac H, Zhang JJ, et al. Clinical applications of fusion imaging in oncology. Nucl Med Biol 1994;21:775-784.